Biotech · Private company
MicuRx
Track this companyFree. Adds MicuRx to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- contezolid acefosamil (IV)/contezolid (PO)Phase 3 · Diabetic Foot InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Linezolid (IV and PO)Phase 3 · Diabetic Foot InfectionClinicalTrials.gov · fetched Nov 12, 2026
- contezolid acefosamilPhase 2 · Skin Diseases, BacterialClinicalTrials.gov · fetched Nov 12, 2026
- linezolid 600 mgPhase 2 · Skin Diseases, BacterialClinicalTrials.gov · fetched Nov 12, 2026
- MRX-8Phase 1 · SafetyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)PHASE3 · RECRUITING · started May 3, 2022ClinicalTrials.gov NCT05369052 · fetched Nov 12, 2026
- Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD CohortsPHASE1 · COMPLETED · started Nov 29, 2020ClinicalTrials.gov NCT04649541 · fetched Nov 12, 2026
- Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionPHASE2 · COMPLETED · started Nov 15, 2018ClinicalTrials.gov NCT03747497 · fetched Nov 12, 2026